Jules A. Maltz is Director & 10% Owner at Hims & Hers Health, Inc. (HIMS). They have made 5 open-market trades across 3 companies since 2013, most recently 2023-09-05.
CIK 0001553254
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $474K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPRT | SELL | 2023-09-05 | 2023-09-07 | $7.31 | $366K | +2.7% | -8.4% | -60.9% |
| HIMS | SELL | 2023-03-02 | 2023-03-06 | $10.10 | $372K | -0.2% | -2.0% | -10.2% |
| HIMS | BUY | 2022-06-14 | 2022-06-16 | $3.66 | $275K | +11.3% | +32.4% | +47.2% |
| HIMS | BUY | 2022-06-07 | 2022-06-09 | $3.99 | $200K | +11.8% | +37.9% | +66.9% |
| SALE | SELL | 2013-12-17 | 2013-12-19 | $26.00 | $6.5M | -11.7% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.